CTLS has specialist clinical trial teams including: bioanalytical and nuclear medicines experts, pathologists, quality assurance consultants and analytical scientists working to FDA, MHRA and UK GCP standards for the testing of new drugs.

CTLS with it’s profound scientific expertise is able to provide bespoke assay development and validation within regulatory guidelines providing unique matrices to particularly low levels of sensitivity.

Specialist work for biomarker validation meeting, FDA/ICH regulatory requirements, can also be undertaken.

CTLS is also able to supply top quality drug free plasma, serum or whole blood for validation of Bioanalytical methods with high integrity.

Providing exceptional value for money and infinite flexibility, CTLS is dedicated to the highest levels of customer satisfaction.